Skip to content

Admiral™ Xtreme ADM050300130LRecalls & reported problems

Medtronic, Inc. · CATH ADM050300130L ADM US 05L300 UL1300 · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08033477064109), received between Jan 28, 2021 and Jan 14, 2025 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Burst Container or Vessel1
  • Detachment of Device or Device Component1
  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 14, 2025Burst Container or Vessel; Burst Container or Vessel

    IT WAS REPORTED THAT A PHYSICIAN WAS ATTEMPTING TO USE AN ADMIRAL XTREME BALLOON DILATATION DEVICE TO TREAT A PATIENT IN THE LEFT PROX/DISTAL PERIPHERAL ARTERY(S) SUPERFICIAL FEMORAL ARTERY REPORTED TO BE CALCIFIED. IFU WAS FOLLOWED. VESSEL WAS POST DILATED. IT WAS REPORTED THAT THE THE ADMIRAL XTREME BALLOON BURST AT, BELOW, OR UNKNOWN RATED BURST PRESSURE DURING FIRST INFLATION. 50/50 CONTRAST WAS USED. THE DEVICE WAS SUCCESSFULLY REMOVED FROM THE PATIENT AND A NEW ADMIRAL XTREME WAS USED WITH NO ISSUES REPORTED. NO HEALTH CONSEQUENCES OR IMPACT

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21146947 ↗
  • InjuryJan 28, 2021Difficult to Remove; Detachment of Device or Device Component; Difficult to Remove; Detachment of Device or Device Component

    PHYSICIAN INTENDED TO USE AN ADMIRAL XTREME PTA BALLOON DURING TREATMENT OF A PLAQUE CTO (CHRONIC TOTAL OCCLUSION-100%) IN THE PATIENT¿S MID RIGHT SUPERFICIAL FEMORAL ARTERY (SFA). MODERATE VESSEL TORTUOSITY AND SLIGHT CALCIFICATION ARE REPORTED. THERE WAS NO DAMAGE NOTED TO THE PRODUCT PACKAGING PRIOR TO USE. NO ISSUES WERE NOTED WHEN REMOVING THE DEVICE FROM THE PACKAGING. AN EVEREST INFLATION DEVICE WAS USED FOR BALLOON INFLATION. IFU WAS FOLLOWED AND THE DEVICE WAS PREPPED WITHOUT ISSUE. THE DEVICE WAS PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS NOTED DURING ADVANCEMENT. IT IS REPORTED DURING WITHDRAWAL OF THE DEVICE THROUGH THE SHEATH A BREAK/FRACTURE OCCURRED ON THE BALLOON AND CATHETER. THE DETACHED PORTIONS OF THE DEVICE WERE REMOVED USING A SNARE. THERE WAS NO INJURY TO THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11244510 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page